What is TTRX's enterprise value?

TTRX (TTRX) reported enterprise value of $89.01M in Q1 2026.

What does enterprise value mean?

Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.

TTRX TTRX Enterprise value

Enterprise value at other companies

Regeneron PharmaceuticalsREGN

$81.42B+18.1%

Bausch Health CompaniesBHC

$21.45B-5.6%

Journey Medical CorporationDERM

$126.43M-10.0%

PTH

Pelthos Therapeutics Inc.PTHS

$68.17M—

Celldex TherapeuticsCLDX

$2.08B+74.4%

Arcutis Biotherapeutics, Inc.ARQT

$3B+57.0%

Other financials

Income statement

See full

Operating income-$1.2M-224%

Net income-$971.0K-196%

EPS (diluted)-$0.03-200%

Balance sheet

See full

Cash & equivalents$11.2M+613%

Total debt$6.0M—

Total equity$6.1M+647%

Total assets$18.6M—

Cash flow

See full

Operating cash flow-$1.6M-448%

Valuation

See full

Market cap$217.45M-17.7%

Returns & leverage

See full

Return on equity-118.8%—

Debt / equity1×—

Current ratio2.2×—

Where this comes from

Calculated from TTRX’s reported figures.

$94.2Mmarket cap+$6.0Mtotal debt−$11.2Mcash and equivalents=$89.01M

The official record: TTRX’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about TTRX's enterprise value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is TTRX's enterprise value?: TTRX (TTRX) reported enterprise value of $89.01M in Q1 2026.
What does enterprise value mean?: Market capitalization plus total debt minus cash, at the quarter end. The cost to acquire the whole business — what an buyer pays for equity and debt, net of the cash they'd inherit.